MICRO-TAG Trademark
MICRO-TAG is a USPTO trademark filed by NERD BIO, LLC. Status: Registered.
Trademark Facts
| Mark | MICRO-TAG |
|---|---|
| Serial Number | 98746046 |
| Registration Number | 7898097 |
| Status | Registered |
| Filing Date | 2024-09-11 |
| Registration Date | 2025-08-19 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 042 (Software & IT) |
| Owner | NERD BIO, LLC |
| Attorney of Record | Jianmin Zhou |
| Prosecution Events | 15 |
| Latest Event | R.PR on 2025-08-19 |
Goods & Services
Reagents forming a fluorescence-emitting enzyme complementation system for research use; reagents for real-time cellular target engagement assay systems for research use; reagents for therapeutics discovery assays systems using DNA-encoded libraries for research use; chemical preparations for use in science other than for medical or veterinary use; biochemicals for in vitro and in vivo for scientific use; biological tissue cultures other than for medical or veterinary purposes; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents for scientific use; reagents for scientific purposes; chemical substances, namely, chemicals for scientific laboratory use; testing reagents for scientific use; universal reagents for automated test systems for scientific or laboratory research use; universal reagents for automated test systems for scientific use; chemical substances, namely, chemicals for scientific use; enzymes for scientific purposes; enzymes, other than for medical use, used in detecting proteins for scientific use; proteins in raw material form for use in science; protein in raw material form for scientific and medical research.; Research and development services in the field of cellular target engagement, discovery and testing of therapeutics; pharmaceutical drug discovery and development services; research and development in the field of therapeutics discovery; research and development in the field of challenging therapeutic targets; research and development of therapeutics for the treatment of various diseases including cancer; technical research in the field of therapeutics; technology research in the field of challenging therapeutic targets; conducting early evaluations in the field of new therapeutics; pharmaceutical products development of new therapeutic molecules belong to the class of small molecules, molecular glues, degraders, peptides and antibodies; pharmaceutical products development of new therapeutic molecules aimed at inhibiting, degrading or modifying disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders.